Tranform lives around the world.
Your 2019 contribution can help end this disease.
Give the Gift of Hope




Recent Posts


FDA Approves Tecentriq Plus Chemotherapy as a First-Line Treatment for Metastatic NSCLC

December 5th, 2019|Hot Topics, News|

On December 3, 2019, the U.S. Food and Drug Administration approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) as a first treatment for patients with metastatic non-squamous non-small cell lung cancer (NSCLC) with no EGFR or ALK changes. This approval is based on the [...]

GO2 Foundation for Lung Cancer Announces Young Innovators Team Award Recipients

December 3rd, 2019|Hot Topics, News|

SAN CARLOS, Calif., Dec. 3, 2019 -- GO2 Foundation for Lung Cancer announced the recipients of the 2019 Young Innovators Team Awards (YITA) today. Two teams of researchers received grants totaling $500,000 for their work developing novel strategies to treat KRAS-mutant non-small cell lung cancer (NSCLC) and examining the impact of age on development, progression, and [...]

The Power of Partnerships—EGFR-Mutant Lung Cancer

November 21st, 2019|Hot Topics|

We fight lung cancer together. That’s a lesson we’ve learned and put into action. Amy C. Moore, PhD, our Director of Science & Research, recently published an article in the International Association for the Study of Lung Cancer online news about the importance of building research models utilizing partnerships [...]

It’s Time to Shine!

October 31st, 2019|Events, Hot Topics|

Can you believe Lung Cancer Awareness Month kicks off tomorrow? Our Shine a Light on Lung Cancer events make it easy for you to celebrate and remember survivors, caregivers and all individuals who have been impacted by the disease. What can you expect at a Shine a Light event? [...]

A Reason to Run: Chris’s Story

October 17th, 2019|Hot Topics|

Chris Palumbo, born and raised in Rochester, New York, is often found running races and participating in endurance challenges in his home city and beyond. He carries the GO2 Foundation flag with him in support of his best friend Jeff Clark, who was diagnosed with stage IV NSCLC ALK+ [...]

Are You Biomarker Savvy?

October 3rd, 2019|Hot Topics|

Every person’s cancer is different. Between all of the lung cancer treatment options available, how can you and your treatment team identify the best path for your individual case? Enter: biomarker testing. Biomarker testing (also called molecular testing) looks for biological changes, like EGFR or ALK, that may be [...]

A Caregiver’s View

September 26th, 2019|Hot Topics, Stories of Hope|

By Danielle Hicks, Chief Patient Officer, GO2 Foundation for Lung Cancer I became a caregiver when my mom was diagnosed with stage 3B lung cancer in 2003. It was one of most terrifying things I had ever had to face up until that point in my life.  She was [...]

Know Your Nodules

September 5th, 2019|Hot Topics|

Decoding lung cancer terminology can be tough—but we’re here to make it easier. In this blog, we’ll help you better understand nodules, also known as lesions, coin lesions, growths, or solitary pulmonary nodules. Nodules are abnormal (yet common) spots that may show up on your lung cancer screening scan [...]

Quality of Life

August 29th, 2019|Hot Topics|

Isn’t that what it’s all about? Whether a CT scan detects lung cancer early or treatment navigation helps you receive biomarker testing or a HelpLine staff member virtually holds a hand, enhancing quality of life for you and all the lung cancer community is of paramount importance. Support can be [...]

Pedaling for Lung Cancer Awareness

August 22nd, 2019|Hot Topics|

How far will someone go to raise awareness about lung cancer? Try 1,800 miles. That’s how far the participants in the Ride Hard Breathe Easy Classic (RHBE) will pedal to recognize the need for enhanced visibility and funding, and to offer hope for future treatments for lung cancer. Started [...]

Welcome to Belong, a New Online Cancer Community

August 21st, 2019|Hot Topics, News|

GO2 Foundation has partnered with Belong.Life to provide patient and caregiver support and education on the world’s largest social network for cancer patients. Within the GO2 Foundation membership area, our social workers, clinical trial specialists, and survivor-volunteers will provide hope, education, and support for those living with lung cancer. Members [...]

FDA Approves Genentech’s Rozlytrek (entrectinib) for ROS1 Non-Small Cell Lung Cancer (NSCLC) and NTRK-Driven Tumors

August 16th, 2019|Hot Topics, News|

On August 15, 2019 the U.S. Food and Drug Administration approved Rozlytrek (entrectinib) for the treatment of patients with ROS1-positive, metastatic non-small cell lung cancer. It was also simultaneously approved for the treatment of patients with any solid tumor that is NTRK fusion-positive, following progression on other therapies. This [...]

GO2 Foundation Presents 2019 Bonnie J. Addario Lectureship Award at ILCC

August 2nd, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer is pleased to announce that it presented Solange Peters, MD, PhD, with the 2019 Bonnie J. Addario Lectureship Award for her emphasis on groundbreaking biomarker research, improving access to care for lung cancer patients worldwide, and supporting the advancement of women in oncology. GO2 Foundation honored [...]